cDNA microarray analysis of altered gene expression in Ara-C-treated leukemia cells

Biochemical and Biophysical Research Communications

Volumn 309, Issue 2, 2003, Pages 351-358

  Takagaki, Kazuchika ^a   Katsuma, Susumu ^a   Horio, Tatsuya ^a   Kaminishi, Yoshinori ^a   Hada, Yuko ^a   Tanaka, Teruo ^a   Ohgi, Tadaaki ^a   Yano, Junichi ^a  

^a NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

Ara C; Asparagine synthetase; cDNA microarray; Chaperone; Erythroid differentiation

Indexed keywords

ASPARAGINASE; ASPARTATE AMMONIA LIGASE; CHAPERONE; CYTARABINE; HEMOGLOBIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; GENE CLUSTER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE;

ARA;

EID: 0041923847     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.009     Document Type: Article

References (23)

1. Cheson B.D. New antimetabolites in the treatment of human malignancies. Semin. Oncol. 19:1992;695-706.
2. Wiley J.S., Jones S.P., Sawyer W.H., Paterson A.R. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia. J. Clin. Invest. 69:1982;479-489.
3. Kufe D.W., Major P.P., Egan E.M., Beardsley G.P. Correlation of cytotoxicity with incorporation of ara-C into DNA. J. Biol. Chem. 255:1980;8997-9000.
4. Housset M., Daniel M.T., Degos L. Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells? Br. J. Haematol. 51:1982;125-129.
5. Cooney D.A., Handschumacher R.E. L-Asparaginase and L-asparagine metabolism. Annu. Rev. Pharmacol. 10:1970;421-440.
6. Nagy K., Pasti G., Bene L., Nagy I. Involvement of Fenton reaction products in differentiation induction of K562 human leukemia cells. Leuk. Res. 19:1995;203-212.
7. Katsuma S., Shiojima S., Hirasawa A., Suzuki Y., Ikawa H., Takagaki K., Kaminishi Y., Murai M., Ohgi T., Yano J., Tsujimoto G. Functional genomic search of G-protein-coupled receptors using microarrays with normalized cDNA library. Methods Enzymol. 345:2002;585-600.
8. Bonaldo M.F., Lennon G., Soares M.B. Normalization and subtraction: two approaches to facilitate gene discovery. Genome Res. 6:1996;791-806.
9. Katsuma S., Shiojima S., Hirasawa A., Suzuki Y., Takagaki K., Murai M., Kaminishi Y., Hada Y., Koba M., Muso E., Miyawaki S., Ohgi T., Yano J., Tsujimoto G. Genomic analysis of a mouse model of immunoglobulin A nephropathy reveals an enhanced PDGF-EDG5 cascade. Pharmacogenom. J. 1:2001;211-217.
10. Katsuma S., Nishi K., Tanigawara K., Ikawa H., Shiojima S., Takagaki K., Kaminishi Y., Suzuki Y., Hirasawa A., Ohgi T., Yano J., Murakami Y., Tsujimoto G. Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling. Biochem. Biophys. Res. Commun. 288:2001;747-751.
11. Katsuma S., Hada Y., Ueda T., Shiojima S., Hirasawa A., Tanoue A., Takagaki K., Ohgi T., Yano J., Tsujimoto G. Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation. Genes Cells. 7:2002;1217-1230.
12. Pruitt K.D., Maglott D.R. RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res. 29:2001;137-140.
13. Steel G.G., Peckham M.J. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int. J. Radiat. Oncol. Biol. Phys. 5:1979;85-91.
14. Badran A., Iwasaki H., Inoue H., Ueda T. Atypical nuclear apoptosis downstream to caspase-3 activation in ara-C treated CCRF-CEM cells. Int. J. Oncol. 22:2003;517-522.
15. Rowley P.T., Ohlsson-Wilhelm B.M., Farley B.A., LaBella S. Inducers of erythroid differentiation in K562 human leukemia cells. Exp. Hematol. 9:1981;32-37.
16. Hsu C.Y., Yung B.Y. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis. Int. J. Cancer. 88:2000;392-400.
17. Reynolds J.E., Yang T., Qian L., Jenkinson J.D., Zhou P., Eastman A., Craig R.W. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res. 54:1994;6348-6352.
18. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature. 378:1995;736-739.
19. Segade F., Gomez-Marquez J. Prothymosin alpha. Int. J. Biochem. Cell Biol. 31:1999;1243-1248.
20. Fang G., Kim C.N., Perkins C.L., Ramadevi N., Winton E., Wittmann S., Bhalla K.N. CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. Blood. 96:2000;2246-2253.
21. Nimmanapalli R., O'Bryan E., Bhalla K. Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. Cancer Res. 61:2001;1799-1804.
22. Scherf U., Ross D.T., Waltham M., Smith L.H., Lee J.K., Tanabe L., Kohn K.W., Reinhold W.C., Myers T.G., Andrews D.T., Scudiero D.A., Eisen M.B., Sausville E.A., Pommier Y., Botstein D., Brown P.O., Weinstein J.N. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24:2000;236-244.
23. Capizzi R.L., Poole M., Cooper M.R., Richards F., Stuart J.J., Jackson D.V., White D.R., Spurr C.L., Hopkins J.O., Muss H.B. Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase. Blood. 63:1984;694-700.